Filing Details

Accession Number:
0001179110-15-006098
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-08 16:21:51
Reporting Period:
2015-04-06
Filing Date:
2015-04-08
Accepted Time:
2015-04-08 16:21:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325713 Bruce Kovner C/O Caxton Corporation
731 Alexander Road, Bldg 2
Princeton NJ 08540
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-06 6,857,143 $1.75 15,278,610 No 4 P Indirect By KFO Holdings LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By KFO Holdings LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,060,860 Direct
Common Stock 5,460,000 Indirect By OB Select Opportunities, LLC
Common Stock 3,100,000 Indirect By Kovner 2012 Family Trust B
Common Stock 250,000 Indirect By Kovner 2011 Family Trust
Common Stock 125,000 Indirect By Kovner 2011-C Investment Trust
Common Stock 125,000 Indirect By Kovner 2011-D Investment Trust
Common Stock 475,000 Indirect By Kovner 2012 Family Trust A
Common Stock 475,000 Indirect By Kovner 2012-B Synta Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-C Synta Investment Trust
Common Stock 475,000 Indirect By Kovner 2012-D Synta Investment Trust
Common Stock 7,761,716 Indirect By CxSynta LLC
Footnotes
  1. These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  2. These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  3. Reflects the transfer of 125,000 shares from Kovner 2011-B Investment Trust to Kovner 2011 Family Trust since the last filing by the Reporting Person.
  4. Reflects the transfer of 475,000 shares from Kovner 2012-A Synta Investment Trust to Kovner 2012 Family Trust A since the last filing by the Reporting Person.
  5. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.